schliessen

Filtern

 

Bibliotheken

Archaeosomes with encapsulated antigens for oral vaccine delivery

Traditional phosphodiester lipid vesicles (liposomes) are not stable and could be easily degraded in the gastrointestinal (GI) tract. We prepared a novel lipid based oral delivery system: archaeosomes, made of the polar lipid fraction E (PLFE) extracted from Sulfolobus acidocaldarius, and tested the... Full description

Journal Title: Vaccine 18 July 2011, Vol.29(32), pp.5260-5266
Main Author: Li, Zhengrong
Other Authors: Zhang, Lihui , Sun, Wenqiang , Ding, Qian , Hou, Yongtai , Xu, Yuhong
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: ScienceDirect (Elsevier B.V.)
ID: ISSN: 0264-410X ; DOI: 10.1016/j.vaccine.2011.05.015
Link: http://dx.doi.org/10.1016/j.vaccine.2011.05.015
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: sciversesciencedirect_elsevierS0264-410X(11)00725-0
title: Archaeosomes with encapsulated antigens for oral vaccine delivery
format: Article
creator:
  • Li, Zhengrong
  • Zhang, Lihui
  • Sun, Wenqiang
  • Ding, Qian
  • Hou, Yongtai
  • Xu, Yuhong
subjects:
  • Archaeosomes
  • Liposomes
  • Oral Delivery
  • Vaccine
ispartof: Vaccine, 18 July 2011, Vol.29(32), pp.5260-5266
description: Traditional phosphodiester lipid vesicles (liposomes) are not stable and could be easily degraded in the gastrointestinal (GI) tract. We prepared a novel lipid based oral delivery system: archaeosomes, made of the polar lipid fraction E (PLFE) extracted from Sulfolobus acidocaldarius, and tested their immunogenic potentials as oral vaccine delivery vehicles. Our study showed that the archaeosomes had significant superior stability in simulated gastric and intestinal fluids, and would help fluorescent labeled antigens to reside longer time in the GI tract after oral administration. The resulted immune responses against model antigen ovalbumin (OVA) were greatly improved, eliciting substantial IgG response systemically as well as IgA response mucosally. In addition, the archaeosomes also facilitated antigen specific CD8+ T cell proliferation. These data indicate that archaeosomes may be a potential vaccine carrier and adjuvant for effective oral immunization.
language: eng
source: ScienceDirect (Elsevier B.V.)
identifier: ISSN: 0264-410X ; DOI: 10.1016/j.vaccine.2011.05.015
fulltext: fulltext
issn:
  • 0264410X
  • 0264-410X
url: Link


@attributes
ID767666749
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordidS0264-410X(11)00725-0
sourceidsciversesciencedirect_elsevier
recordidTN_sciversesciencedirect_elsevierS0264-410X(11)00725-0
sourcesystemOther
display
typearticle
titleArchaeosomes with encapsulated antigens for oral vaccine delivery
creatorLi, Zhengrong ; Zhang, Lihui ; Sun, Wenqiang ; Ding, Qian ; Hou, Yongtai ; Xu, Yuhong
ispartofVaccine, 18 July 2011, Vol.29(32), pp.5260-5266
identifierISSN: 0264-410X ; DOI: 10.1016/j.vaccine.2011.05.015
subjectArchaeosomes ; Liposomes ; Oral Delivery ; Vaccine
descriptionTraditional phosphodiester lipid vesicles (liposomes) are not stable and could be easily degraded in the gastrointestinal (GI) tract. We prepared a novel lipid based oral delivery system: archaeosomes, made of the polar lipid fraction E (PLFE) extracted from Sulfolobus acidocaldarius, and tested their immunogenic potentials as oral vaccine delivery vehicles. Our study showed that the archaeosomes had significant superior stability in simulated gastric and intestinal fluids, and would help fluorescent labeled antigens to reside longer time in the GI tract after oral administration. The resulted immune responses against model antigen ovalbumin (OVA) were greatly improved, eliciting substantial IgG response systemically as well as IgA response mucosally. In addition, the archaeosomes also facilitated antigen specific CD8+ T cell proliferation. These data indicate that archaeosomes may be a potential vaccine carrier and adjuvant for effective oral immunization.
languageeng
sourceScienceDirect (Elsevier B.V.)
version2
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://dx.doi.org/10.1016/j.vaccine.2011.05.015$$EView_record_in_ScienceDirect
openurlfulltext$$Topenurlfull_article
search
creatorcontrib
0Li, Zhengrong
1Zhang, Lihui
2Sun, Wenqiang
3Ding, Qian
4Hou, Yongtai
5Xu, Yuhong
titleArchaeosomes with encapsulated antigens for oral vaccine delivery
descriptionTraditional phosphodiester lipid vesicles (liposomes) are not stable and could be easily degraded in the gastrointestinal (GI) tract. We prepared a novel lipid based oral delivery system: archaeosomes, made of the polar lipid fraction E (PLFE) extracted from Sulfolobus acidocaldarius, and tested their immunogenic potentials as oral vaccine delivery vehicles. Our study showed that the archaeosomes had significant superior stability in simulated gastric and intestinal fluids, and would help fluorescent labeled antigens to reside longer time in the GI tract after oral administration. The resulted immune responses against model antigen ovalbumin (OVA) were greatly improved, eliciting substantial IgG response systemically as well as IgA response mucosally. In addition, the archaeosomes also facilitated antigen specific CD8+ T cell proliferation. These data indicate that archaeosomes may be a potential vaccine carrier and adjuvant for effective oral immunization.
subject
0Archaeosomes
1Liposomes
2Oral Delivery
3Vaccine
general
0English
1Elsevier Ltd
210.1016/j.vaccine.2011.05.015
3ScienceDirect (Elsevier B.V.)
4ScienceDirect Journals (Elsevier)
sourceidsciversesciencedirect_elsevier
recordidsciversesciencedirect_elsevierS0264-410X(11)00725-0
issn
00264410X
10264-410X
rsrctypearticle
creationdate2011
addtitleVaccine
searchscope
0sciversesciencedirect_elsevier
1elsevier_sciencedirect
scope
0sciversesciencedirect_elsevier
1elsevier_sciencedirect
startdate20110718
enddate20110718
citationpf 5260 pt 5266 vol 29 issue 32
sort
titleArchaeosomes with encapsulated antigens for oral vaccine delivery
authorLi, Zhengrong ; Zhang, Lihui ; Sun, Wenqiang ; Ding, Qian ; Hou, Yongtai ; Xu, Yuhong
creationdate20110718
lso0120110718
facets
frbrgroupid6645676957813560110
frbrtype5
languageeng
creationdate2011
topic
0Archaeosomes
1Liposomes
2Oral Delivery
3Vaccine
collectionScienceDirect Journals (Elsevier)
prefilterarticles
rsrctypearticles
creatorcontrib
0Li, Zhengrong
1Zhang, Lihui
2Sun, Wenqiang
3Ding, Qian
4Hou, Yongtai
5Xu, Yuhong
jtitleVaccine
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Li
1Zhang
2Sun
3Ding
4Hou
5Xu
aufirstZhengrong
au
0Li, Zhengrong
1Zhang, Lihui
2Sun, Wenqiang
3Ding, Qian
4Hou, Yongtai
5Xu, Yuhong
atitleArchaeosomes with encapsulated antigens for oral vaccine delivery
jtitleVaccine
addtitleVaccine
risdate20110718
volume29
issue32
spage5260
epage5266
pages5260-5266
issn0264-410X
formatjournal
genrearticle
ristypeJOUR
abstractTraditional phosphodiester lipid vesicles (liposomes) are not stable and could be easily degraded in the gastrointestinal (GI) tract. We prepared a novel lipid based oral delivery system: archaeosomes, made of the polar lipid fraction E (PLFE) extracted from Sulfolobus acidocaldarius, and tested their immunogenic potentials as oral vaccine delivery vehicles. Our study showed that the archaeosomes had significant superior stability in simulated gastric and intestinal fluids, and would help fluorescent labeled antigens to reside longer time in the GI tract after oral administration. The resulted immune responses against model antigen ovalbumin (OVA) were greatly improved, eliciting substantial IgG response systemically as well as IgA response mucosally. In addition, the archaeosomes also facilitated antigen specific CD8+ T cell proliferation. These data indicate that archaeosomes may be a potential vaccine carrier and adjuvant for effective oral immunization.
pubElsevier Ltd
doi10.1016/j.vaccine.2011.05.015
date2011-07-18